This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kocken, C. H. M.
Right arrow Articles by Thomas, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kocken, C. H. M.
Right arrow Articles by Thomas, A. W.

 Previous Article  |  Next Article 

Infection and Immunity, January 1999, p. 43-49, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

High-Level Expression of Plasmodium vivax Apical Membrane Antigen 1 (AMA-1) in Pichia pastoris: Strong Immunogenicity in Macaca mulatta Immunized with P. vivax AMA-1 and Adjuvant SBAS2

Clemens H. M. Kocken,1 Martin A. Dubbeld,1 Annemarie Van Der Wel,1 Jack T. Pronk,2 Andrew P. Waters,3 Jan A. M. Langermans,1 and Alan W. Thomas1,*

Department of Parasitology, Biomedical Primate Research Centre, 2280 GH Rijswijk,1 Kluyver Laboratory of Biotechnology, Industrial Biotechnology Section, Delft University of Technology, 2628 BC Delft,2 and Leiden University Medical Centre, 2300 RC Leiden,3 The Netherlands

Received 12 May 1998/Returned for modification 24 July 1998/Accepted 5 October 1998

The apical membrane antigen 1 (AMA-1) family is a promising family of malaria blood-stage vaccine candidates that have induced protection in rodent and nonhuman primate models of malaria. Correct conformation of the protein appears to be essential for the induction of parasite-inhibitory responses, and these responses appear to be primarily antibody mediated. Here we describe for the first time high-level secreted expression (over 50 mg/liter) of the Plasmodium vivax AMA-1 (PV66/AMA-1) ectodomain by using the methylotrophic yeast Pichia pastoris. To prevent nonnative glycosylation, a conservatively mutagenized PV66/AMA-1 gene (PV66Delta glyc) lacking N-glycosylation sites was also developed. Expression of the PV66Delta glyc ectodomain yielded similar levels of a homogeneous product that was nonglycosylated and was readily purified by ion-exchange and gel filtration chromatographies. Recombinant PV66Delta glyc43-487 was reactive with conformation-dependent monoclonal antibodies. With the SBAS2 adjuvant, Pichia-expressed PV66Delta glyc43-487 was highly immunogenic in five rhesus monkeys, inducing immunoglobulin G enzyme-linked immunosorbent assay titers in excess of 1:200,000. This group of monkeys had a weak trend showing lower cumulative parasite loads following a Plasmodium cynomolgi infection than in the control group.


* Corresponding author. Mailing address: BPRC, Dept. of Parasitology, Lange Kleiweg 157, 2288 GJ Rijswijk, The Netherlands. Phone: (31) 15-2842 538. Fax: (31) 15-2843 986. E-mail: thomas{at}bprc.nl.


Infection and Immunity, January 1999, p. 43-49, Vol. 67, No. 1
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Wickramarachchi, T., Premaratne, P. H., Perera, K. L. R. L., Bandara, S., Kocken, C. H. M., Thomas, A. W., Handunnetti, S. M., Udagama-Randeniya, P. V. (2006). Natural Human Antibody Responses to Plasmodium vivax Apical Membrane Antigen 1 under Low Transmission and Unstable Malaria Conditions in Sri Lanka. Infect. Immun. 74: 798-801 [Abstract] [Full Text]  
  • Dutta, S., Kaushal, D. C., Ware, L. A., Puri, S. K., Kaushal, N. A., Narula, A., Upadhyaya, D. S., Lanar, D. E. (2005). Merozoite Surface Protein 1 of Plasmodium vivax Induces a Protective Response against Plasmodium cynomolgi Challenge in Rhesus Monkeys. Infect. Immun. 73: 5936-5944 [Abstract] [Full Text]  
  • Giersing, B., Miura, K., Shimp, R., Wang, J., Zhou, H., Orcutt, A., Stowers, A., Saul, A., Miller, L. H., Long, C., Singh, S. (2005). Posttranslational Modification of Recombinant Plasmodium falciparum Apical Membrane Antigen 1: Impact on Functional Immune Responses to a Malaria Vaccine Candidate. Infect. Immun. 73: 3963-3970 [Abstract] [Full Text]  
  • Gaffar, F. R., Yatsuda, A. P., Franssen, F. F. J., de Vries, E. (2004). Erythrocyte Invasion by Babesia bovis Merozoites Is Inhibited by Polyclonal Antisera Directed against Peptides Derived from a Homologue of Plasmodium falciparum Apical Membrane Antigen 1. Infect. Immun. 72: 2947-2955 [Abstract] [Full Text]  
  • Yadava, A., Ockenhouse, C. F. (2003). Effect of Codon Optimization on Expression Levels of a Functionally Folded Malaria Vaccine Candidate in Prokaryotic and Eukaryotic Expression Systems. Infect. Immun. 71: 4961-4969 [Abstract] [Full Text]  
  • OZWARA, H., LANGERMANS, J. A. M., MAAMUN, J., FARAH, I. O., YOLE, D. S., MWENDA, J. M., WEILER, H., THOMAS, A. W. (2003). EXPERIMENTAL INFECTION OF THE OLIVE BABOON (PAPIO ANUBIS) WITH PLASMODIUM KNOWLESI: SEVERE DISEASE ACCOMPANIED BY CEREBRAL INVOLVEMENT. Am J Trop Med Hyg 69: 188-194 [Abstract] [Full Text]  
  • Kocken, C. H. M., Withers-Martinez, C., Dubbeld, M. A., van der Wel, A., Hackett, F., Blackman, M. J., Thomas, A. W. (2002). High-Level Expression of the Malaria Blood-Stage Vaccine Candidate Plasmodium falciparum Apical Membrane Antigen 1 and Induction of Antibodies That Inhibit Erythrocyte Invasion. Infect. Immun. 70: 4471-4476 [Abstract] [Full Text]  
  • Dutta, S., Ware, L. A., Barbosa, A., Ockenhouse, C. F., Lanar, D. E. (2001). Purification, Characterization, and Immunogenicity of a Disulfide Cross-Linked Plasmodium vivax Vaccine Candidate Antigen, Merozoite Surface Protein 1, Expressed in Escherichia coli. Infect. Immun. 69: 5464-5470 [Abstract] [Full Text]